Industry Experts

Jenny Greig, PhD is Franklin Biolabs Senior Vice President, and Head of Operations. Prior to joining Franklin Biolabs, Jenny was part of the University of Pennsylvania’s Gene Therapy Program (GTP) and during her nearly 15 years there progressed from being a postdoctoral researcher investigating muscle and liver transduction with gene therapy vectors to being Executive Director overseeing a team of scientists focused on genome editing, oncology, and capsid discovery.

Following two previously successful Investigational New Drug (IND) submissions, she recently led her team through the development of an AAV-delivered, meganuclease-mediated gene insertion approach for the treatment of ornithine transcarbamylase (OTC) deficiency to FDA clearance for iECURE to initiate the OTC-HOPE clinical trial. Jenny is a member of the American Society for Gene and Cell Therapy (ASGCT). She is also the first author of more than 15 peer-reviewed scientific papers and is co-inventor on nine patent applications.
Jenny holds a Bachelor of Science (Hons) in Pharmacology and a PhD in Gene Therapeutics from the University of Glasgow in Scotland.